OTCMKTS:GOVX
Geovax Labs Stock News
$1.45
+0.0499 (+3.56%)
At Close: May 01, 2024
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q1 2021 Results - Earnings Call Transcript
10:16am, Sunday, 09'th May 2021
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q1 2021 Results - Earnings Call Transcript
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q4 2020 Results - Earnings Call Transcript
11:41am, Wednesday, 24'th Mar 2021
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q4 2020 Results - Earnings Call Transcript
GeoVax Spikes 80% On COVID-19 Research Grant Report
11:36am, Monday, 11'th Jan 2021
GeoVax (NASDAQ: GOVX) shares are trading sharply higher on Monday after the company announced it was awarded an NIH grant to advance its COVID-19 vaccine development. GeoVax is a U.S.-based clinical-s
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q4 2020 Results - Earnings Call Transcript
03:01am, Sunday, 08'th Nov 2020
GeoVax Labs, Inc. (GOVX) CEO David Dodd on Q4 2020 Results - Earnings Call Transcript
GeoVax Labs, Inc.'s (GOVX) CEO David Dodd on Q3 2020 Results - Earnings Call Transcript
09:36am, Friday, 06'th Nov 2020
GeoVax Labs, Inc.'s (GOVX) CEO David Dodd on Q3 2020 Results - Earnings Call Transcript
GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update
05:00pm, Thursday, 05'th Nov 2020
Public Offering Completed in September 2020 Provides Resources to Accelerate COVID-19 Vaccine and Immuno-Oncology Programs
GeoVax to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020 and Provide Corporate Update
10:08am, Friday, 30'th Oct 2020
Conference call to be held Friday, November 6, at 8:15 a.m. Eastern Time
GeoVax CEO David Dodd to Participate in Virtual Webinar Hosted by Outsourced Pharma
09:00am, Wednesday, 28'th Oct 2020
ATLANTA, GA, Oct. 28, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherap
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
09:00am, Monday, 26'th Oct 2020
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherap
Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
12:00am, Tuesday, 20'th Oct 2020
Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says
12:48pm, Friday, 16'th Oct 2020
A study coordinated by the World Health Organization has indicated that remdesivir, along with three other potential drug treatments for the coronavirus, has "little or no effect" on death rates among
Majoration pour vie autonome
09:04am, Friday, 09'th Oct 2020
Incessible et insaisissable, la majoration pour la vie autonome (MVA) est une aide financière permettant le maintien à domicile d'une personne handicapée. Depuis le 1er décembre 2019, l’ancien c
Audit Faults MVA For Suspicious Addresses, 'Points' Not Applied
01:06pm, Wednesday, 30'th Sep 2020
The department issued driver's licenses to thousands who used questionable addresses, also failing to properly track driving infractions.
Engagement with anti-vaccine Facebook posts trebles in one month
05:00am, Saturday, 19'th Sep 2020
Exclusive: Guardian analysis prompts calls for new drive to combat conspiracy theories
